Intellectual Property Rights and Innovation: MNCs in Pharmaceutical Industry in India after TRIPS

The paper discusses several patent cases to argue that MNCs are aggressively asserting their patent rights not for getting genuine patents which they are entitled to but for preventing generic competition. The paper also finds that the MNCs are more keen to import patented drugs and market these in the country rather than to manufacture these and contribute to technological progress.